US Centers for Disease Control and Prevention Installs TAP’s CompacT SelecT for Public Health Disease-Prevention Activities

5 Nov 2010
Sarah Sarah
Marketing / Sales

The Automation Partnership's CompacT SelecT automated cell culture system has been set up at the prestigious Centers for Disease Control and Prevention (CDC) in the USA for crucial cell culture programmes and to eliminate contamination risk.

CDC’s Cell Culture Development Laboratory in Atlanta, Georgia, has recently installed the CompacT SelecT and researchers there are currently validating the system for the culture of MDCK cells that are used for growing influenza viruses. In the future, they plan to validate the system to grow Vero E6 cell lines for use in generating other viruses.

Increased demand for MDCK cell lines during the 2009 H1N1 pandemic prompted CDC to decide to move to an automated system to preserve staff resources and decrease the risk of laboratory contamination.

Tim Ward, Director of Cell Culture at TAP, said: “We are delighted a major disease prevention centre will be using our system for crucial cell culture programmes. The CDC’s use of CompacT SelecT will enhance productivity and help eliminate contamination risk, which will improve the reliability and consistency of cells. Those receiving cells from the CDC will benefit by having greater confidence that they are using optimum quality cells for applications such as vaccine research and production.”

CompacT SelecT™ SC Automated stem cell culture system

TAP Biosystems

CompacT SelecT SC cultures multiple stem cell lines in parallel in T-Flasks and plates without cross contamination. Offers reliable and consistent maintenance, expansion and differentiation of stem cell lines. CompacT SelecT™ is the leading automated cell culture system, used in labs across commercial and academic life science. It is now available with new options to enable the culturing of complex cell lines for oncology programmes, stem cell research and toxicity studies.CompacT SelecT SC provides a solution for core stem cell facilities and academic labs conducting basic stem cell research programs. Can also be used as a platform for the provision of stem cells for drug discovery screening programs and cell therapy research programs.CompacT SelecT grows cells from multiple cell lines in T-flasks for cell line maintenance and expansion. It can generate assay-ready plates on demand for cell-based screening and assay development.CompacT SelecT™ SC Automated stem cell culture system Automates: Expansion and maintenance of multiple cell lines Sub culturing Expanding cell numbers through the seeding of a number of flasks Transient transfection Harvesting and plating of cells for assays and screening Harvesting of cells in flasks for off-line processing Incubation of up to 90 T 175 format flasks and 210 plates Cell counting and viability measurement Processing of single, Triple and 10 layer (HYPERFlask) flasks Plating into 96 and 384-well plates

(1)

Links

Tags